Arbutus Biopharma (ABUS) stock forecast for 2024. Forecast tables and graphs.







Your Path to Profits: The Best Trading Platforms for New Traders

October 3, 2024 Your Path to Profits: The Best Trading Platforms for New Traders

Welcome to trading! If you’re a newb looking to get to financial freedom, choosing the right trading platform is step one. With so…
Mastering Trading Indicators: Your Essential Toolkit For Success

October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success

Often investors struggle to identify profitable trades consistently. Trading indicators provide essential data to guide trading decisions. This article explains key indicators and…
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…

Arbutus Biopharma (ABUS) stock forecast for 2024

Updated: October 11, 2024 (15:16)

Sector: Healthcare

The share price of Arbutus Biopharma Corp. (ABUS) now

What analysts predict: $5
52-week High/Low: $4.725 / $1.69

50/200 Day Moving Average: $3.936 / $3.164

This figure corresponds to the Average Price over the previous 50/200 days. For Arbutus Biopharma stocks, the 50-day moving average is the resistance level today.

For Arbutus Biopharma stocks, the 200-day moving average is the resistance level today.

Are you interested in Arbutus Biopharma Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arbutus Biopharma stock price in 2024. How much will one Arbutus Biopharma share be worth in 2024? Is it worth taking profit / loss on ABUS stock now or waiting? What are analysts' forecasts for Arbutus Biopharma stock?

We forecast Arbutus Biopharma stock performance using neural networks based on historical data on ABUS stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Arbutus Biopharma Corp. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Arbutus Biopharma analysts is $5. Today 200 Day Moving Average is the support level (3.164 $). 50 Day Moving Average is the resistance level (3.936 $).




Historical and forecast chart of Arbutus Biopharma Corp. stock

The chart below shows the historical price of Arbutus Biopharma stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ABUS stock price can be found in the table below.


Arbutus Biopharma Corporation, a biopharmaceutical company, is engaged in the discovery, development and commercialization of a drug for patients with chronic hepatitis B virus (HBV) infection in the United States. Its HBV product portfolio consists of AB-836, a capsid inhibitor that can inhibit HBV replication by preventing the assembly of functional viral capsids; and AB-423, which is undergoing preclinical studies. The company is also developing RNAi preparations that use the RNA interference pathway, which allows a new approach to the treatment of diseases.

Trending Themes in the Healthcare Sector

Arbutus Biopharma (ABUS) Forecast for 2024

Month Target Pes. Opt. Vol., %
Nov 3.83 3.75 3.93 4.73 %
Dec 3.84 3.67 3.97 7.57 %

Arbutus Biopharma information and performance

Arbutus Biopharma Address

100-8900 GLENLYON PARKWAY, BURNABY, BC, CA

Market Capitalization: 715 484 000 $

Market capitalization of the Arbutus Biopharma Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ABUS shares in the company outstanding by the market price of one share.

EBITDA: -80 989 000 $

EBITDA of Arbutus Biopharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.45

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.629
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 57.35

Enterprise Value (EV) /Revenue

EV To EBITDA: -5.64

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 188782000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Arbutus Biopharma price target for 2024 by month


Target values for the price of one Arbutus Biopharma share for Nov 2024.

The weighted average target price per Arbutus Biopharma share in Nov 2024 is: 3.83.
In Nov, the Positive dynamics for Arbutus Biopharma Corp. shares will prevail with possible monthly volatility of 4.728% volatility is expected.
Pessimistic target level: 3.75
Optimistic target level: 3.93

Target values for the price of one Arbutus Biopharma share for Dec 2024.

The weighted average target price per Arbutus Biopharma share in Dec 2024 is: 3.84.
In Dec, the Positive dynamics for Arbutus Biopharma Corp. shares will prevail with possible monthly volatility of 7.571% volatility is expected.
Pessimistic target level: 3.67
Optimistic target level: 3.97



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.